Biogen to reapply for Irish HSE funding for MS drug Fampyra
Posted: Tue Jun 17, 2014 1:07 am
The makers of a drug that helps people with multiple sclerosis to walk are to make a fresh application to have it covered by the Health Service Executive-funded drug schemes. People with MS, who say Fampridine (known commercially as Fampyra) has greatly increased their mobility, have criticised the HSE for not reimbursing the cost of the drug on the long-term illness scheme...... Read More - http://www.ms-uk.org/ampyra